What is Innovasis?
Innovasis specializes in developing and providing bioactive solutions tailored for spinal fusion procedures. The company's product portfolio encompasses a range of critical medical devices, including cervical and thoracolumbar implants, cranial implants, and advanced biologics. Leveraging proprietary technologies such as HA PEEK and HAnano, Innovasis aims to significantly enhance osseointegration and deliver superior performance in interbody fusion devices. Their focus is on serving healthcare professionals and institutions dedicated to advancing spinal surgery and treatment, positioning them as a key innovator in the medical technology landscape.
How much funding has Innovasis raised?
Innovasis has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
What's next for Innovasis?
The enterprise-level funding context suggests Innovasis is poised for significant expansion and market penetration. This strategic investment will likely fuel further research and development into novel bioactive materials and implant designs, potentially broadening their product offerings and enhancing existing technologies. Expect Innovasis to scale its manufacturing capabilities and sales operations to meet growing demand, further solidifying its position as a leader in innovative spinal care solutions. The company's commitment to advancing spinal treatment through cutting-edge materials indicates a future focused on clinical adoption and market leadership.
See full Innovasis company page
